Shares of ProtoKinetix, Incorporated (OTCMKTS:PKTX – Get Free Report) passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.01 and traded as low as $0.0061. ProtoKinetix shares last traded at $0.0069, with a volume of 170,187 shares traded.
ProtoKinetix Price Performance
The business has a 50-day moving average of $0.01 and a 200 day moving average of $0.01.
About ProtoKinetix
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc and changed its name to ProtoKinetix, Incorporated in July 2003.
Further Reading
- Five stocks we like better than ProtoKinetix
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Do you know what Amazon is planning for January 1?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for ProtoKinetix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProtoKinetix and related companies with MarketBeat.com's FREE daily email newsletter.
